Related Experiment Videos
Mycophenolate mofetil-induced villous atrophy
D Ducloux1, Y Ottignon, S Semhoun-Ducloux
1Department of Nephrology and Renal Transplantation, Centre Hospitalier Universitaire, Besançon, France.
Transplantation
|November 10, 1998
Summary
Mycophenolate mofetil (MMF) can cause severe diarrhea in renal transplant patients. This side effect may be linked to villous atrophy, which resolved after discontinuing MMF.
Area of Science:
- Nephrology
- Immunology
- Gastroenterology
Background:
- Mycophenolate mofetil (MMF) is an immunosuppressant used to prevent acute renal transplant rejection.
- Diarrhea is a common side effect of MMF, but its cause is not fully understood.
Observation:
- A renal transplant recipient developed severe diarrhea during MMF treatment.
- The patient had no prior gastrointestinal symptoms before starting MMF.
Findings:
- The diarrhea was associated with villous atrophy, a condition affecting the small intestine lining.
- Villous atrophy resolved within months after MMF was discontinued.
Implications:
- This case suggests a potential link between MMF and drug-induced villous atrophy.
- Understanding this mechanism could improve management of MMF-related gastrointestinal side effects in transplant patients.